Recent Posts
- New company Aptadir to develop gene reactivating therapy for fragile X
- FRAXA, Marvel Biosciences team up to test therapy in fragile X animal models
- Protocols for US trials of zatolmilast amended to increase accessibility
- Several initiatives on tap for Fragile X Awareness Month in July
- Education, empowerment aim of International Fragile X Conference
- FDA clears Phase 2 trial of oral SPG601 in men with fragile X
- LivJoy Foundation funds research in understudied female fragile X population
- Two-med combo normalized behavior, improved memory in fragile X mice
- Simple blood test for 2 biomarkers may help identify fragile X
- Researchers uncover new disrupted genes linked to fragile X